# Autism Therapeutics Ltd: Form D filing

Autism Therapeutics Ltd, a biotechnology company in London, United Kingdom, filed a Form D with the SEC in 2011. The latest, on March 17, 2011, reports an offering of $450,000 with nothing sold yet.

Find out what Autism Therapeutics Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Autism%20Therapeutics%20Ltd%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Autism%20Therapeutics%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fautism-therapeutics-ltd-1515753)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Autism%20Therapeutics%20Ltd%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Autism%20Therapeutics%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fautism-therapeutics-ltd-1515753)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 145-157 ST. JOHN STEET, London, United Kingdom, EC14P
- Phone: 44 777 5915639
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: United Kingdom
- Year incorporated: 2010
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1515753

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 17, 2011 | New notice | $450,000 | $0 | $450,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1515753/000151575311000001/0001515753-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Charles A Merriman | Executive Officer, Director |  |
| Heather A Keohane | Executive Officer, Director |  |
| Michael A Snape | Executive Officer, Director |  |

[Every Form D from the week of Mar 14, 2011](https://specstream.ai/data/form-d/week/2011-03-14) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Autism Therapeutics Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).